Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s)

Nadia Bouabdallaoui1, Anique Ducharme2

  • 1Department of Medicine, Montreal Heart Institute, Université de Montréal, 5000, Belanger East, Montreal, Quebec, H1T1C8, Canada.

Insights

Heart failure readmissions remain high despite programs. Reorganizing care to target high-risk patients and involve primary care providers is crucial for improving heart failure management.

Area of Science:

  • Cardiology
  • Geriatrics
  • Healthcare Management

Background:

  • Heart failure (HF) is a leading cause of hospitalization in the elderly, incurring significant healthcare expenses.
  • Current multidisciplinary post-discharge programs have not effectively reduced patient readmission rates.
  • There is a need for improved strategies in heart failure care management.

Purpose of the Study:

  • To review recent developments in heart failure care.
  • To identify strategies for reducing heart failure readmissions.
  • To assess the applicability of new tools and expertise in HF programs.

Main Methods:

  • Review of recent literature and data on heart failure care programs.
  • Analysis of strategies for patient risk stratification.
  • Evaluation of the role of primary care providers and patient empowerment.

Main Results:

  • Global reorganization of heart failure care is recommended, focusing on high-risk patients.
  • Increased involvement of primary care providers in patient care plans is suggested.
  • New tools and interdisciplinary expertise show promise but require pragmatic assessment for routine use.

Conclusions:

  • Future heart failure programs should prioritize pragmatic patient assessment to identify those most likely to benefit from multidisciplinary care.
  • Delegating low-risk patient management to trained primary care providers and empowering patients are key strategies.
  • Effective integration of new technologies and expertise is essential for optimizing heart failure management and reducing readmissions.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
329